ktwo agre acquir share
downgrad rate market perform market outperform
share ktwo follow announc
compani acquir mp morn ktwo report
enter definit merger agreement acquir
per share bln premium thursday close
premium past averag share price all-cash offer valu
ktwo sale mln midpoint sale
guidanc mln
acquisit add lead orthoped neurosurg
posit gain increment share bln global spine market
indic area interest perhap inorgan past
offer strong foothold complex deform spine arena ktwo
previous guid sale growth mln
compani also continu expand innov degen mi portfolio
primari focu implant given profil posit ktwo
attract public spine name institut ownership
consid extens experi believ like
deal goe said yet know detail
transact put togeth believ repres fair valuat given
compar takeout med-tech spine see figur note
transact term includ termin fee mln paid ktwo
circumst deal termin previou price
target base ev/sal multipl appli sale estim
mln
thomson reuter jmp secur llc
compani report jmp secur llc
comment purchas ktwo expect materi
dilut impact full-year ep thu reiter year guidanc
expect review financi estim upon close
deal acquisit expect close late compani also
announc ktwo ceo eric major expect appoint presid
spine divis
report read conjunct import disclosur inform includ attest regul analyst certif
ktwo repres compani acquir research univers sinc prior today deal
recent transact exclud cgnt novadaq bard ldr hold
higher valuat compar ktwo respect compar ev/sal
averag valuat acquisit price/sal exclud purchas
cryocor
former research coverag chartnet purchas priced target companytarget symbolacquir companypric medic bardbcrbecton holdingsldrhzimm medicalmrexcelsior union management nashknsyroy conceptskciapax partner capit endovascularmendjohnson cryoboston medicalttgregener incorporateddjor neuromodulationansist jude medic medicalclsrjohnson mln ltm sale group hold inc ktwo
global medic devic compani focus develop commerci innov technolog
treatment spinal patholog focu complex spine mi technolog compani complex spine product use
difficult challeng spine procedur deform primarili scoliosi trauma tumor manag set
tackl market base belief procedur typic receiv higher rate posit insur coverag often
gener revenu per procedur tradit degen spine procedur
risk invest thesi valuat includ
regulatori risk failur gain product approv and/or failur pass regulatori inspect result warn letter product
litig risk medic devic space litigi compani may su issu relat ip infring may ip
infring upon could subject signific cost could caus compani need rais capit
profit compani yet profit may need rais capit reach profit potenti dilut current sharehold
ktwo also compet far larger compani signific resourc
research analyst prepar report does/do herebi certifi view present report accord my/our
person view secur issuer discuss report mandat sec regul ac part my/our compens
directli indirectli relat specif view recommend express herein certif made
oblig set forth sec regul ac person entiti may use purpos certif made
base my/our analysi date report public i/w assum oblig updat certif reflect fact
circumst event may subsequ come my/our attent sign david turkali daniel stauder
jmp secur current make market secur inc stryker corpor inc
jmp secur expect receiv intend seek compens invest bank servic inc
stryker corpor next month
market outperform mo jmp secur expect stock price outperform relev market indic next month
market perform mp jmp secur expect stock price perform line relev market indic next month
market under-perform mu jmp secur expect stock price under-perform relev market indic next month
jmp secur research rate invest bank servic august
co
servic
stock price chart rate price chang
note first annot denot initi coverag year whichev shorter target price list target price n/a
accord finra rule chart reflect price rang chang rate price target end
recent calendar quarter action reflect note annot stock price chart jmp secur
jmp secur llc firm compens research analyst like firm employe base firm profit includ
revenu firm institut sale trade invest bank depart well qualiti servic activ
perform intend benefit firm institut client data prepar jmp secur llc inform
purpos base inform avail public sourc believ reliabl guarante
accuraci complet opinion project express herein reflect judgment date subject chang
without notic data neither intend consid offer sell solicit basi contract
purchas secur financi product jmp secur llc affili jmp group llc harvest capit strategi llc
respect partner director offic associ may long short posit may act market maker may
purchas sell posit secur mention herein jmp secur llc affili may perform perform seek
perform invest bank advisori servic may act manag co-manag public offer secur
compani mention herein reader assum jmp secur llc solicit busi compani cover
report member sale trade depart provid oral and/or written market opinion trade strategi client
reflect person opinion stock subject firm research report research analyst discuss trade
strategi client sometim reflect short-term expect price secur subject research report
trade strategi distinct analyst fundament rate stock base upon analyst view compar
stock coverag relev time period copyright right reserv jmp secur llc jmp secur
llc member finra sipc
director research
director equiti
director sale trade
